Stock 003017 ZHE JIANG DAYANG BIOTECH GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhe Jiang Dayang Biotech Group Co., Ltd.

Equities

003017

CNE100004736

Commodity Chemicals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
19.16 CNY +1.81% Intraday chart for Zhe Jiang Dayang Biotech Group Co., Ltd. -1.59% -21.22%
04-28 Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. announced that it has received CNY 14.7143 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd. CI
04-26 Zhe Jiang Dayang Biotech Group Co., Ltd. Proposes Final Cash Dividend for 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 3,105 2,508 1,646
Enterprise Value (EV) 1 2,715 2,276 1,501
P/E ratio 26.8 x 35.8 x 20 x
Yield 1.16% 1.44% 0.72%
Capitalization / Revenue 4.58 x 3.2 x 1.56 x
EV / Revenue 4 x 2.91 x 1.42 x
EV / EBITDA 21.2 x 20.6 x 13.7 x
EV / FCF 203 x -21.9 x 34 x
FCF Yield 0.49% -4.56% 2.94%
Price to Book 3.24 x 2.53 x 1.61 x
Nbr of stocks (in thousands) 84,000 84,000 83,177
Reference price 2 36.96 29.86 19.79
Announcement Date 25/04/21 19/04/22 24/04/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 554.7 584.2 621.8 678.3 783.2 1,058
EBITDA 1 93.65 105.2 113.2 128.4 110.3 109.6
EBIT 1 69.28 79.49 83.2 97.23 66.3 50.41
Operating Margin 12.49% 13.61% 13.38% 14.33% 8.47% 4.76%
Earnings before Tax (EBT) 1 55.37 75.15 86.73 100.3 76.14 57.45
Net income 1 50.26 70.8 79.5 91.61 70.01 80.73
Net margin 9.06% 12.12% 12.79% 13.5% 8.94% 7.63%
EPS 2 1.300 1.207 1.264 1.378 0.8334 0.9900
Free Cash Flow 1 25.2 -4.512 30.26 13.39 -103.8 44.17
FCF margin 4.54% -0.77% 4.87% 1.97% -13.25% 4.17%
FCF Conversion (EBITDA) 26.91% - 26.74% 10.43% - 40.31%
FCF Conversion (Net income) 50.15% - 38.07% 14.61% - 54.71%
Dividend per Share - 0.3571 0.2143 0.4286 0.4286 0.1429
Announcement Date 23/04/18 20/06/19 09/03/20 25/04/21 19/04/22 24/04/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 33.8 - - - - -
Net Cash position 1 - 7.28 30.1 390 232 145
Leverage (Debt/EBITDA) 0.3608 x - - - - -
Free Cash Flow 1 25.2 -4.51 30.3 13.4 -104 44.2
ROE (net income / shareholders' equity) 17.7% 18.2% 16.9% 12.6% 7.18% 8.17%
ROA (Net income/ Total Assets) 8.84% 8.91% 8.34% 6.48% 3.18% 2.19%
Assets 1 568.6 794.3 953.3 1,413 2,199 3,693
Book Value Per Share 2 8.200 6.990 7.910 11.40 11.80 12.30
Cash Flow per Share 2 1.000 0.4800 0.8400 0.8300 1.570 1.640
Capex 1 26.7 44.1 61.8 125 93.4 105
Capex / Sales 4.82% 7.54% 9.95% 18.4% 11.93% 9.89%
Announcement Date 23/04/18 20/06/19 09/03/20 25/04/21 19/04/22 24/04/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Commodity Chemicals

1st Jan change Capi.
ZHE JIANG DAYANG BIOTECH GROUP CO., LTD. Stock Zhe Jiang Dayang Biotech Group Co., Ltd.
-21.22% 209M
AIR LIQUIDE Stock Air Liquide
+5.41% 105B
SABIC Stock SABIC
-3.11% 64.71B
PT CHANDRA ASRI PACIFIC TBK Stock PT Chandra Asri Pacific Tbk
+73.33% 49.72B
WANHUA CHEMICAL GROUP CO., LTD. Stock Wanhua Chemical Group Co., Ltd.
+17.24% 38.6B
LYONDELLBASELL INDUSTRIES N.V. Stock LyondellBasell Industries N.V.
+6.13% 32.54B
WESTLAKE CORPORATION Stock Westlake Corporation
+12.77% 19.94B
NINGXIA BAOFENG ENERGY GROUP CO., LTD. Stock Ningxia Baofeng Energy Group Co., Ltd.
+15.03% 16.92B
HENGLI PETROCHEMICAL CO.,LTD. Stock Hengli Petrochemical Co.,Ltd.
+19.06% 15.2B
RONGSHENG PETROCHEMICAL CO., LTD. Stock Rongsheng Petrochemical Co., Ltd.
+6.28% 14.39B
Other Commodity Chemicals
  1. Stock Market
  2. Equities
  3. 003017 Stock
  4. Financials Zhe Jiang Dayang Biotech Group Co., Ltd.